TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Maintains Target Price $70

TD Cowen维持布鲁克(BRKR.US)持有评级，维持目标价70美元

moomoo资讯 · 11/06 08:31 · 评级/大行评级

TD Cowen analyst Daniel Brennan maintains $Bruker Corp (BRKR.US)$ with a hold rating, and maintains the target price at $70.

According to TipRanks data, the analyst has a success rate of 50.8% and a total average return of 14.4% over the past year.

AnalystRecentRatingAutoNews_203162_20241106_e020df1ea579fde62835b37cc3b8305a5a043a53_1730899835844504_mm_en

Furthermore, according to the comprehensive report, the opinions of $Bruker Corp (BRKR.US)$'s main analysts recently are as follows:

Post the Q3 report, Bruker experienced continued softness in the China market and in the biopharma sector.
The company faced a challenging reporting period within a difficult macroeconomic situation. Estimates are being adjusted to align with the reduced fiscal 2024 targets. Nevertheless, there is confidence that the company's strong positioning in multi-omics and materials sciences will enable it to capitalize on the anticipated demand resurgence in the biopharma sector and the Chinese market.
Bruker's third-quarter results fell short of expectations, and the company revised its organic sales growth forecast for fiscal 2024 downwards, attributing the slower pace to a delayed resurgence in China and emerging biopharma sectors. Analysts have pointed out that the adjustment in guidance was not a result of a significant market downturn in the third quarter, but was instead due to previous forecasts being too optimistic. Despite this, management has expressed a confident outlook for 2025.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

TD Cowen分析师Daniel Brennan维持$布鲁克 (BRKR.US)$持有评级，维持目标价70美元。

根据TipRanks数据显示，该分析师近一年总胜率为50.8%，总平均回报率为14.4%。

AnalystRecentRatingAutoNews_203162_20241106_e020df1ea579fde62835b37cc3b8305a5a043a53_1730899835844504_mm_sc

此外，综合报道，$布鲁克 (BRKR.US)$近期主要分析师观点如下：

发帖Q3报告后，Bruker在中国市场和生物制药板块持续疲软。
公司在艰难的宏观经济形势下面临挑战性的报告期。估计正在调整以与降低的2024财年目标相一致。尽管如此，公司在多组学和材料科学领域的强劲定位将使其能够利用预期的生物制药板块和中国市场需求回暖。
Bruker第三季度业绩未达预期，并将其2024财年的有机销售增长预测下调，归因于中国和新兴生物制药领域复苏速度较慢。分析师指出，对指导方面的调整并非是由于第三季度市场大幅下降，而是由于先前的预测过于乐观。尽管如此，管理层对2025年表现表达了信心。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Maintains Target Price $70

TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Maintains Target Price $70

风险及免责提示

声明